Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,664 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dynamic monitoring of circulating tumor DNA reveals outcomes and genomic alterations in patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy.
Zou H, Liu W, Wang X, Wang Y, Wang C, Qiu C, Liu H, Shan D, Xie T, Huang W, Sui W, Yi S, An G, Xu Y, Ma T, Wang J, Qiu L, Zou D. Zou H, et al. Among authors: zou d. J Immunother Cancer. 2024 Mar 4;12(3):e008450. doi: 10.1136/jitc-2023-008450. J Immunother Cancer. 2024. PMID: 38443094 Free PMC article.
Favorable outcomes of front-line risk-adapted therapy in young patients with diffuse large B-cell lymphoma with clinically or biologically high-risk features.
Zou H, Liu W, Wang Y, Shan D, Xie T, Li R, Liu H, Huang W, Fu M, Wang T, Lyu R, Deng S, Sui W, Xu Y, Yi S, An G, Qiu L, Zou D. Zou H, et al. Among authors: zou d. Chin Med J (Engl). 2024 Jul 5;137(13):1620-1622. doi: 10.1097/CM9.0000000000002940. Epub 2023 Dec 7. Chin Med J (Engl). 2024. PMID: 38061986 Free PMC article. No abstract available.
Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma.
Liu W, Liu W, Zou H, Chen L, Huang W, Lv R, Xu Y, Liu H, Shi Y, Wang K, Wang Y, Xiong W, Deng S, Yi S, Sui W, Peng G, Ma Y, Wang H, Lv L, Wang J, Wei J, Qiu L, Zheng W, Zou D. Liu W, et al. Among authors: zou h, zou d. J Immunother Cancer. 2024 Apr 16;12(4):e008857. doi: 10.1136/jitc-2024-008857. J Immunother Cancer. 2024. PMID: 38631712 Free PMC article.
5,664 results